Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of death and disability in the United States, with an estimated 12 million people who remain undiagnosed. The impact of COPD in terms of quality of life and cost of care is substantial, yet studies have found inadequacies in current health systems to meet the complex needs of COPD patients.
In 2021, NuvoAir initiated a small pilot with the roll-out of virtual COPD clinical services in the United States. Data show successful engagement and reported health outcomes with 80% reporting fewer COPD related hospitalizations since joining the NuvoAir Clinical Service.
In this white paper, you will more learn more about: